Process and reagent for the determination of α-amylase

Claim 2

Method for determining α-amylase in a sample comprising adding to said sample: (i) an α-amylase substrate, (ii) a monoclonal antibody which binds to α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 86060601 and which increases enzymatic activity of α-amylase, and (iii) one or more auxiliary enzymes which act on a cleavage product formed by action of α-amylase on said α-amylase substrate, and measuring a cleavage product formed by action of said one or more auxiliary enzymes on the cleavage product formed by the action of α-amylase on its substrate as a measure of α-amylase in the sample.

Claim 3

Method according to claim 1 wherein said substrate is a D-maltooligosaccharide with 2 to 10 glucose units.

Claim 4

Method according to claim 2 wherein said substrate is a D-maltooligosaccharide with 4 to 8 glucose units.

Claim 5

Method according to claim 3 wherein said substrate is maltotetraose and said one or more auxiliary enzyme comprise maltose phosphorylase, β-phosphoglucomutase and glucose-6-phosphate dehydrogenase.

Claim 6

Method according to claim 1, wherein said α-amylase substrate is a chromophoric substrate.

Claim 7

Method according to claim 5 wherein said chromophoric group is a nitrophenyl radical.

Claim 8

Method according to claim 1, wherein said one or more auxiliary enzymes comprises α-glucosidase.

Claim 9

Method according to claim 1, wherein said substrate is maltoheptaose and said one or more auxiliary enzymes comprise α-glucosidase, hexokinase and glucose-6-phosphate dehydrogenase.

Claim 10

Method according to claim 1, wherein said one or more auxiliary enzymes comprise α-glucosidase and β-glucosidase.

Claim 11

Method according to claim 1, wherein said monoclonal antibody which increases activity of α-amylase is produced by hybridoma cell line ECACC 86020601 or hybridoma cell line ECACC 86020602.

Claim 12

Method according to claim 1, wherein said substrate contains at least one ethylidene protective group.

Claim 13

Method according to claim 1, wherein said α-amylase substrate is a chromophoric substrate and said substrate contains at least one ethylidene protective group.

Claim 14

Method for determining one of salivary α-amylase or pancreatic α-amylase in sample, comprising adding to said sample: (i) an α-amylase substrate, (ii) a monoclonal antibody which binds to α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 86060601 and which increases enzymatic activity of α-amylase, (iii) one or more auxiliary enzymes which act on a cleavage product formed by action of α-amylase on said α-amylase substrate, (iv) a monoclonal antibody which inhibits the one of salivary α-amylase or pancreatic α-amylase not being determined and measuring a cleavage product formed by action of said one or more auxiliary enzymes on the cleavage product formed by the action of non-inhibited α-amylase on its substrate as a measure of salivary α-amylase or pancreatic α-amylase in the sample.

Claim 15

Method for determining one of salivary α-amylase or pancreatic α-amylase in sample, comprising adding to said sample: (i) an α-amylase substrate, (ii) a monoclonal antibody which binds to α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 86060601 and which increases enzymatic activity of α-amylase, (iii) one or more auxiliary enzymes which act on a cleavage product formed by action of α-amylase on said α-amylase substrate, (iv) a monoclonal antibody which inhibits the one of salivary α-amylase or pancreatic α-amylase not being determined and measuring a cleavage product formed by action of said one or more auxiliary enzymes on the cleavage product formed by the action of non-inhibited α-amylase on its substrate as a measure of salivary α-amylase or pancreatic α-amylase in the sample.

Claim 16

Method according to claim 13, wherein said α-amylase isoenzyme to be determined is pancreatic α-amylase and said inhibiting monoclonal antibody specifically inhibits salivary α-amylase and is produced by hybridoma cell line NCACC 84122003.

Claim 17

Reagent for the determination of α-amylase comprising an α-amylase substrate, one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, a system for measuring a cleavage product of said one or more auxiliary enzymes, and at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 86060601.

Claim 18

Reagent for the determination of α-amylase comprising an α-amylase substrate, one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, a system for measuring a cleavage product of said one or more auxiliary enzymes, and at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 86060601.

Claim 19

Reagent according to claim 15, wherein said monoclonal antibody which increases α-amylase activity is selected from the group consisting of monoclonal antibodies produced by hybridoma cell lines ECACC 86020601 and ECACC 86020602.

Claim 20

Reagent according to claim 15, wherein said α-amylase substrate is a chromophoric substrate.

Claim 21

Reagent according to claim 17, wherein said substrate is a D-maltooligosaccharide with 2 to 10 glucose units.

Claim 22

Reagent according to claim 18, wherein said reagent comprises maltoheptaose as substrate and α-glucosidase, hexokinase and glucose-6-phosphate dehydrogenase as said one or more auxiliary enzymes.

Claim 23

Reagent according to claim 15, wherein said chromophoric group is a nitrophenyl radical.

Claim 24

Reagent according to claim 15, wherein said reagent contains α-glucosidase as said one or more auxiliary enzymes.

Claim 25

Reagent according to claim 15, wherein said one or more auxiliary enzymes comprise α-glucosidase and β-glucosidase.

Claim 26

Reagent according to claim 15, wherein said reagent comprises maltotetraose as substrate and maltose phosphorylase, β-phosphoglucomutase and glucose-6-phosphate dehydrogenase as said one or more auxiliary enzymes.

Claim 27

Reagent according to claim 15, wherein said substrate contains at least one ethylidene group.

Claim 28

Reagent according to claim 15, wherein said α-amylase substrate is a chromophoric substrate containing at least one ethylidene group.

Claim 29

Reagent for determining an α-amylase isoenzyme, comprising: (i) an α-amylase substrate, (ii) one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, (iii) a system for measuring a cleavage product of said one or more auxiliary enzymes, (iv) at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 8606061, (v) and an additional monoclonal antibody which inhibits activity of the isoenzyme not being determined.

Claim 30

Reagent for determining an α-amylase isoenzyme, comprising: (i) an α-amylase substrate, (ii) one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, (iii) a system for measuring a cleavage product of said one or more auxiliary enzymes, (iv) at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022203 and ECACC 8606061, (v) and an additional monoclonal antibody which inhibits activity of the isoenzyme not being determined.

Claim 31

Reagent according to claim 26 wherein said additional monoclonal antibody is a monoclonal antibody against salivary α-amylase produced by hybridoma cell line NCACC 84122003.

Claim 32

Reagent according to claim 27 further comprising monoclonal antibody against salivary α-amylase produced by hybridoma cell line NCACC 84111301.

Claim 33

Reagent according to claim 27, wherein said reagent further comprises at least one of the monoclonal antibodies against salivary α-amylase formed by hybridoma cell lines NCACC 85022203 and ECACC 86060601.

Claim 34

Kit for determination of α-amylase comprising separate samples, each of which is in a separate container, of (i) an α-amylase substrate, (ii) one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, (iii) a system for measuring a cleavage product formed by action of said one or more auxiliary enzymes in the cleavage product formed by action of α-amylase on its substrate, and (iv) at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022003 and ECACC 86060601.

Claim 35

Kit for determination of α-amylase comprising separate samples, each of which is in a separate container, of (i) an α-amylase substrate, (ii) one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, (iii) a system for measuring a cleavage product formed by action of said one or more auxiliary enzymes in the cleavage product formed by action of α-amylase on its substrate, and (iv) at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022003 and ECACC 86060601.

Claim 36

Kit for determination of an α-amylase isoenzyme comprising separate portions of each of (i) an α-amylase substrate, (ii) one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, (iii) a system for measuring a cleavage product formed by action of said one or more auxiliary enzymes in the cleavage product formed by action of α-amylase on its substrate, (iv) at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022003 and ECACC 86060601, and (v) a monoclonal antibody which inhibits activity of the α-amylase isoenzymes not being determined.

Claim 37

Kit for determination of an α-amylase isoenzyme comprising separate portions of each of (i) an α-amylase substrate, (ii) one or more auxiliary enzymes which cleave a cleavage product formed by action of α-amylase on its substrate, (iii) a system for measuring a cleavage product formed by action of said one or more auxiliary enzymes in the cleavage product formed by action of α-amylase on its substrate, (iv) at least one monoclonal antibody which increases activity of α-amylase in the presence of all of the monoclonal antibodies produced by hybridoma cell lines NCACC 84111301, NCACC 84122003, NCACC 85022003 and ECACC 86060601, and (v) a monoclonal antibody which inhibits activity of the α-amylase isoenzymes not being determined.